| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |